blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1490038

EP1490038 - HYBRID SYSTEM FOR SOLUBILIZING PHARMACEUTICALLY ACTIVE SUBSTANCES IN POLYMER MATRICES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.06.2010
Database last updated on 28.09.2024
Most recent event   Tooltip19.10.2012Lapse of the patent in a contracting state
New state(s): TR
published on 21.11.2012  [2012/47]
Applicant(s)For all designated states
Beiersdorf AG
Unnastrasse 48
20245 Hamburg / DE
[2005/01]
Inventor(s)01 / NIERLE, Jens
Hönermoor 12
21147 Hamburg / DE
02 / GÄDE, Christian
Königsberger Str. 73
21629 Neu Wulmstorf / DE
 [2005/01]
Application number, filing date03722347.621.03.2003
[2005/01]
WO2003EP02953
Priority number, dateDE200211286422.03.2002         Original published format: DE 10212864
[2005/01]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO03080035
Date:02.10.2003
Language:DE
[2003/40]
Type: A1 Application with search report 
No.:EP1490038
Date:29.12.2004
Language:DE
The application published by WIPO in one of the EPO official languages on 02.10.2003 takes the place of the publication of the European patent application.
[2004/53]
Type: B1 Patent specification 
No.:EP1490038
Date:05.08.2009
Language:DE
[2009/32]
Search report(s)International search report - published on:EP02.10.2003
ClassificationIPC:A61K9/70
[2005/01]
CPC:
A61K9/0014 (EP,US); A61K9/7053 (EP,US); A61K47/20 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/01]
TitleGerman:MISCHSYSTEM ZUR LÖSLICHKEITSVERMITTLUNG VON PHARMAZEUTISCHEN WIRKSTOFFEN IN POLYMERMATRIZES[2005/01]
English:HYBRID SYSTEM FOR SOLUBILIZING PHARMACEUTICALLY ACTIVE SUBSTANCES IN POLYMER MATRICES[2005/01]
French:SYSTEME DE MELANGE POUR SOLUBILISER DES AGENTS ACTIFS PHARMACEUTIQUES DANS DES MATRICES POLYMERES[2005/01]
Entry into regional phase22.10.2004National basic fee paid 
22.10.2004Designation fee(s) paid 
22.10.2004Examination fee paid 
Examination procedure22.10.2004Examination requested  [2004/53]
23.03.2009Communication of intention to grant the patent
23.06.2009Fee for grant paid
23.06.2009Fee for publishing/printing paid
Opposition(s)07.05.2010No opposition filed within time limit [2010/28]
Fees paidRenewal fee
31.03.2005Renewal fee patent year 03
31.03.2006Renewal fee patent year 04
02.04.2007Renewal fee patent year 05
31.03.2008Renewal fee patent year 06
31.03.2009Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY05.08.2009
CZ05.08.2009
DK05.08.2009
EE05.08.2009
FI05.08.2009
IE05.08.2009
IT05.08.2009
NL05.08.2009
RO05.08.2009
SE05.08.2009
SI05.08.2009
SK05.08.2009
TR05.08.2009
BG05.11.2009
GR06.11.2009
PT05.12.2009
HU06.02.2010
AT21.03.2010
LU21.03.2010
BE31.03.2010
MC31.03.2010
[2012/47]
Former [2012/43]CY05.08.2009
CZ05.08.2009
DK05.08.2009
EE05.08.2009
FI05.08.2009
IE05.08.2009
IT05.08.2009
NL05.08.2009
RO05.08.2009
SE05.08.2009
SI05.08.2009
SK05.08.2009
BG05.11.2009
GR06.11.2009
PT05.12.2009
HU06.02.2010
AT21.03.2010
LU21.03.2010
BE31.03.2010
MC31.03.2010
Former [2012/42]CY05.08.2009
CZ05.08.2009
DK05.08.2009
EE05.08.2009
FI05.08.2009
IE05.08.2009
IT05.08.2009
NL05.08.2009
RO05.08.2009
SE05.08.2009
SI05.08.2009
SK05.08.2009
BG05.11.2009
GR06.11.2009
PT05.12.2009
HU06.02.2010
AT21.03.2010
BE31.03.2010
MC31.03.2010
Former [2012/37]CY05.08.2009
CZ05.08.2009
DK05.08.2009
EE05.08.2009
FI05.08.2009
IE05.08.2009
IT05.08.2009
NL05.08.2009
RO05.08.2009
SE05.08.2009
SI05.08.2009
SK05.08.2009
BG05.11.2009
GR06.11.2009
PT05.12.2009
AT21.03.2010
BE31.03.2010
MC31.03.2010
Former [2011/43]CZ05.08.2009
DK05.08.2009
EE05.08.2009
FI05.08.2009
IE05.08.2009
IT05.08.2009
NL05.08.2009
RO05.08.2009
SE05.08.2009
SI05.08.2009
SK05.08.2009
BG05.11.2009
GR06.11.2009
PT05.12.2009
AT21.03.2010
BE31.03.2010
MC31.03.2010
Former [2011/14]CZ05.08.2009
DK05.08.2009
EE05.08.2009
FI05.08.2009
IE05.08.2009
IT05.08.2009
NL05.08.2009
RO05.08.2009
SE05.08.2009
SI05.08.2009
SK05.08.2009
BG05.11.2009
GR06.11.2009
PT05.12.2009
BE31.03.2010
MC31.03.2010
Former [2010/46]CZ05.08.2009
DK05.08.2009
EE05.08.2009
FI05.08.2009
IE05.08.2009
NL05.08.2009
RO05.08.2009
SE05.08.2009
SI05.08.2009
SK05.08.2009
BG05.11.2009
GR06.11.2009
PT05.12.2009
MC31.03.2010
Former [2010/23]CZ05.08.2009
DK05.08.2009
EE05.08.2009
FI05.08.2009
IE05.08.2009
NL05.08.2009
RO05.08.2009
SE05.08.2009
SI05.08.2009
SK05.08.2009
BG05.11.2009
PT05.12.2009
Former [2010/22]CZ05.08.2009
DK05.08.2009
EE05.08.2009
FI05.08.2009
IE05.08.2009
NL05.08.2009
RO05.08.2009
SE05.08.2009
SI05.08.2009
BG05.11.2009
PT05.12.2009
Former [2010/20]DK05.08.2009
EE05.08.2009
FI05.08.2009
IE05.08.2009
NL05.08.2009
SE05.08.2009
SI05.08.2009
BG05.11.2009
PT05.12.2009
Former [2010/18]FI05.08.2009
NL05.08.2009
SE05.08.2009
SI05.08.2009
BG05.11.2009
PT05.12.2009
Former [2010/16]FI05.08.2009
NL05.08.2009
SE05.08.2009
SI05.08.2009
PT05.12.2009
Former [2010/11]FI05.08.2009
NL05.08.2009
SE05.08.2009
SI05.08.2009
Former [2010/10]FI05.08.2009
NL05.08.2009
SE05.08.2009
Former [2010/09]FI05.08.2009
SE05.08.2009
Cited inInternational search[A]US5702720  (EFFING JOCHEM [DE], et al) [A] 1-12* column 1, lines 35-62; examples 1-7; claims 1-18 *;
 [A]US6221383  (MIRANDA JESUS [US], et al) [A] 1-12 * column 2, lines 44-55; examples 44-65; claims 1-4; table 2 * * column 33, lines 14-25 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.